Literature DB >> 7459184

Pharmacokinetics and analgesic effect of ketamine in man.

J A Clements, W S Nimmo.   

Abstract

The pharmacokinetics and analgesic effect of i.v. ketamine in doses of 125 microgram kg-1 and 250 microgram kg-1 were determined in five healthy volunteers. Analgesia was measured with the submaximal effort tourniquet test. Both doses of ketamine prolonged the period of pain-free ischaemic exercise while the plasma ketamine concentration was greater than 100 ng ml-1. Ketamine was distributed rapidly (T 1/2 alpha = 17 min). The elimination half-life was 186 min.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7459184     DOI: 10.1093/bja/53.1.27

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  54 in total

1.  Assessment of the effect of dextromethorphan and ketamine on the acute nociceptive threshold and wind-up of the second pain response in healthy male volunteers.

Authors:  A M Hughes; J Rhodes; G Fisher; M Sellers; J W Growcott
Journal:  Br J Clin Pharmacol       Date:  2002-06       Impact factor: 4.335

2.  Bioavailability prediction based on molecular structure for a diverse series of drugs.

Authors:  Joseph V Turner; Desmond J Maddalena; Snezana Agatonovic-Kustrin
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

Review 3.  Psychiatric drugs bind to classical targets within early exocytotic pathways: therapeutic effects.

Authors:  Henry A Lester; Julie M Miwa; Rahul Srinivasan
Journal:  Biol Psychiatry       Date:  2012-07-06       Impact factor: 13.382

4.  Modulatory effects of ketamine, risperidone and lamotrigine on resting brain perfusion in healthy human subjects.

Authors:  Sergey Shcherbinin; Orla Doyle; Fernando O Zelaya; Sara de Simoni; Mitul A Mehta; Adam J Schwarz
Journal:  Psychopharmacology (Berl)       Date:  2015-07-31       Impact factor: 4.530

5.  Pharmacokinetic-pharmacodynamic modelling of ketamine in six neurotraumatised intensive care patients.

Authors:  Youssef Hijazi; Carole Bodonian; François Salord; Françoise Bressolle; Roselyne Boulieu
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

Review 6.  Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Authors:  Panos Zanos; Ruin Moaddel; Patrick J Morris; Lace M Riggs; Jaclyn N Highland; Polymnia Georgiou; Edna F R Pereira; Edson X Albuquerque; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

Review 7.  Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder.

Authors:  B G Bunney; J Z Li; D M Walsh; R Stein; M P Vawter; P Cartagena; J D Barchas; A F Schatzberg; R M Myers; S J Watson; H Akil; W E Bunney
Journal:  Mol Psychiatry       Date:  2014-11-04       Impact factor: 15.992

Review 8.  Intravenous anaesthetic agents. Pharmacokinetic-pharmacodynamic relationships.

Authors:  B N Swerdlow; F O Holley
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

9.  Magnesium sulfate attenuates tourniquet pain in healthy volunteers.

Authors:  Tsuyoshi Satsumae; Hiroshi Yamaguchi; Shinichi Inomata; Makoto Tanaka
Journal:  J Anesth       Date:  2012-10-07       Impact factor: 2.078

Review 10.  Clinically important drug interactions with intravenous anaesthetics in older patients.

Authors:  Helge Eilers; Claus Niemann
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.